Published in Blood Weekly, July 28th, 1997
Ex vivo expansion of stem cells is important for a number of clinical applications, including retroviral-mediated gene transfer for use in certain gene therapy applications and the production of antigen-presenting dendritic cells, which are under study for use as anti-cancer vaccines.
CellPro's Ceprate SC Stem Cell Concentration System has been incorporated into over 20 clinical gene therapy protocols and the company expects to begin Phase I/II clinical studies of anti-cancer dendritic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.